2026-01-15 - Analysis Report
**Company Overview**
Lam Research Corp. is a leading developer and manufacturer of semiconductor processing equipment.

**Return Rate Comparison**
| Stock | Cumulative Return |
| --- | --- |
| LRCX | 288.68% |
| VOO (S&P 500) | 92.89% |

The cumulative return of LRCX is significantly higher than that of VOO.

**Divergence**
| Divergence |
| --- |
| Max: 215.90 |
| Min: -14.70 |
| Current: 195.80 |
| Relative Divergence: 91.30% |

LRCX's current position in relation to past data is in the top 91.30% percentile.

**Analysis of Alpha, Beta, and CAGR**
| Period | CAGR | MDD | Alpha | Beta | Cap(B) |
| --- | --- | --- | --- | --- | --- |
| 2016-2018 | 1.0% | 34.2% | -2.0% | 1.6 | 17.2B |
| 2017-2019 | 38.0% | 34.2% | 21.0% | 1.7 | 36.9B |
| 2018-2020 | 57.0% | 34.2% | 36.0% | 1.5 | 59.5B |
| 2019-2021 | 105.0% | 24.5% | 62.0% | 1.6 | 90.7B |
| 2020-2022 | -11.0% | 49.0% | -9.0% | 1.6 | 53.0B |
| 2021-2023 | -14.0% | 49.0% | -15.0% | 1.8 | 98.8B |
| 2022-2024 | -47.0% | 42.4% | -66.0% | 1.9 | 91.1B |
| 2023-2025 | 150.0% | 43.7% | 88.0% | 2.0 | 215.9B |

Stock performance has been volatile, with significant fluctuations in CAGR and MDD.

**Moving Average Analysis**
| Period | SMA |
| --- | --- |
| 5-day | $212.58 |
| 20-day | $186.73 |
| 60-day | $166.03 |

Stock price has seen a sharp decline in recent days, with a 5-day SMA above the current price.

**RSI, PPO, and Delta Prevalent Relative Divergence**
| Indicator | Value |
| --- | --- |
| RSI | 70.35 |
| PPO | 1.19 |
| Delta Prevalent Relative Divergence | -5.70 |

RSI and PPO indicate a neutral to slightly overbought condition.

**Risk Indicator and Expected Return**
| Indicator | Value |
| --- | --- |
| MRI | 0.70 |
| Expected Return (%) | 13.80% |

Risk indicator and expected return indicate a medium-risk investment with a possible long-term return of 13.80%.

**Recent News and Events**
- [2026-01-14] Lam Research (NASDAQ:LRCX) Stock Price Down 2.6% - Here's What Happened
- [2026-01-09] Why Is Lam Research (LRCX) Stock Soaring Today
- [2026-01-14] Stifel Raises Price Target with a Buy Rating
- [2026-01-12] What Could Keep Driving Lam Research Stock Higher?
- [2026-01-13] How to Get Paid to Buy LRCX at a Steep Discount
- [2026-01-14] Does Stronger AI-Focused Wafer-Fab Demand Recast the Bull Case For Lam Research (LRCX)?

Recent news indicates a sharp decline in stock price and possible reasons for future growth.

**Analyst Opinions**
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.77 (~Buy)
- Opinions: 30
- Target Price (avg/high/low): 182.80 / 265.00 / 115.00

Analysts generally have a buy recommendation, with a target price of $182.80 and an average opinion of 1.77.

**Recent Earnings Analysis**
| Date | EPS | Revenue |
| --- | --- | --- |
| 2025-10-24 | 1.24 | 5.32B$ |
| 2025-04-25 | 1.04 | 4.72B$ |
| 2025-01-31 | 0.93 | 4.38B$ |
| 2024-10-28 | 0.86 | 4.17B$ |

Earnings per share (EPS) has generally increased over time, while revenue has fluctuated.

**Revenue and Profitability Analysis**
| Quarter | Revenue | Profit Margin |
| --- | --- | --- |
| 2025-09-30 | $5.32B | 50.43% |
| 2025-06-30 | $5.17B | 50.08% |
| 2025-03-31 | $4.72B | 49.02% |
| 2024-12-31 | $4.38B | 47.37% |
| 2024-09-30 | $4.17B | 48.05% |

Revenue has increased over the past year, while profit margin has generally decreased.

**Capital and Profitability Analysis**
| Quarter | Equity | ROE |
| --- | --- | --- |
| 2025-09-30 | $10.19B | 15.39% |
| 2025-06-30 | $9.86B | 17.44% |
| 2025-03-31 | $9.51B | 13.99% |
| 2024-12-31 | $8.81B | 13.52% |
| 2024-09-30 | $8.47B | 13.18% |

Equity has generally increased over the past year, while return on equity (ROE) has fluctuated.

**Comprehensive Analysis**

Lam Research Corp. has seen a significant increase in stock price in recent years, with a cumulative return of 288.68%. However, the company's stock price has seen a sharp decline in recent days, with a 5-day SMA above the current price. Analysts generally have a buy recommendation, with a target price of $182.80 and an average opinion of 1.77. The company's revenue has increased over the past year, while profit margin has generally decreased. Equity has generally increased over the past year, while ROE has fluctuated. The risk indicator and expected return indicate a medium-risk investment with a possible long-term return of 13.80%.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.